Omni Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.15 M
- Company Age 35 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.60 M
- Revenue Growth 1.57%
- Profit Growth -62.93%
- Ebitda -281.05%
- Net Worth -8.13%
- Total Assets -2.79%
About Omni Laboratories
Omni Laboratories Private Limited (OLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 1990 and has a history of 35 years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹5.60 M.
Sandeep Gupta, Sharad Gupta, and Sanjay Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1990PTC039046
- Company No.
039046
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Omni Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Gupta  | Director | 08-Jun-1990 | Current |
| Sharad Gupta | Director | 08-Jun-1990 | Current |
| Sanjay Gupta | Director | 17-Sep-2012 | Current |
Financial Performance of Omni Laboratories.
Omni Laboratories Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 1.57% increase. The company also saw a substantial fall in profitability, with a 62.93% decrease in profit. The company's net worth dipped by a decrease of 8.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Omni Laboratories?
In 2020, Omni Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Omnison Pharma Private LimitedSanjay Gupta is a mutual person
Charges (Loans)
₹5.60 M
₹0
Charges Breakdown by Lending Institutions
- Uttar Pradesh Financial Corporation : 0.23 Cr
- Union Bank Of India : 0.19 Cr
- Hdfc Bank Limited : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2016 | Hdfc Bank Limited | ₹1.45 M | Open |
| 24 Jul 2009 | Union Bank Of India | ₹0.40 M | Open |
| 31 May 2002 | Union Bank Of India | ₹1.50 M | Open |
| 23 Apr 1991 | Uttar Pradesh Financial Corporation | ₹2.25 M | Open |
How Many Employees Work at Omni Laboratories?
Unlock and access historical data on people associated with Omni Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Omni Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omni Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.